Litcius/Paper detail

Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study

Kosuke Ebina, Tôru Hirano, Yuichi Maeda, Wataru Yamamoto, Motomu Hashimoto, Koichi Murata, Akira Ōnishi, Sadao Jinno, Ryota Hara, Yonsu Son, Hideki Amuro, Tohru Takeuchi, Ayaka Yoshikawa, Masaki Katayama, Keiichi Yamamoto, Makoto Hirao, Yasutaka Okita, Atsushi Kumanogoh, Ken Nakata

2021Clinical Rheumatology25 citationsDOIOpen Access PDF

Topics & Concepts

MedicineTofacitinibDiscontinuationRheumatoid arthritisInternal medicineAdverse effectRheumatologyRheumatoid factorConcomitantPrednisoloneProportional hazards modelCohortGastroenterologySurgeryRheumatoid Arthritis Research and TherapiesPharmacovigilance and Adverse Drug ReactionsSpondyloarthritis Studies and Treatments
Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study | Litcius